By Sophia Dourou
A group of pharmaceutical companies urged the Court of Appeal Tuesday to partly reverse £100 million ($132 million) in sanctions over an alleged price-fixing cartel, arguing that a tribunal made factual and legal mistakes when upholding the fines.
Read Full Article